Related Experiment Video

Updated: Aug 8, 2026

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
10:18

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

Surface phenotype and immunoglobulin levels in B-cell chronic lymphocytic leukaemia

A Orfao1, M Gonzalez, J F San Miguel

  • 1Servicio de Hematologia, Hospital Clinico Universitario, Salamanca, Spain.

Haematologia
|January 1, 1990
PubMed

Insights

Low immunoglobulin (Ig) levels in B-cell chronic lymphocytic leukemia (B-CLL) patients correlate with advanced disease, not specific cell phenotypes. Hypogammaglobulinaemia indicates a higher tumor burden in B-CLL.

Area of Science:

  • Hematology
  • Immunology
  • Oncology

Background:

  • B-cell chronic lymphocytic leukemia (B-CLL) is a heterogeneous lymphoproliferative disorder.
  • Immunoglobulin (Ig) levels and expression are critical in B-CLL pathogenesis and prognosis.
  • Understanding the relationship between Ig levels and disease characteristics is vital for patient management.

Purpose of the Study:

  • To investigate the association between serum Ig levels and the immunological phenotype of B-CLL.
  • To analyze the correlation between Ig levels and clinicohaematological features in B-CLL patients.
  • To determine if hypogammaglobulinaemia in B-CLL relates to tumor burden or cellular phenotype.

Main Methods:

  • Analysis of serum immunoglobulin levels in 126 B-CLL patients.
  • Assessment of B-cell surface phenotype using flow cytometry.
  • Correlation of Ig levels with clinical data, including organomegaly, cytopenias, bone marrow patterns, and disease stage.

Main Results:

  • 70% of B-CLL patients exhibited decreased Ig levels, predominantly IgM and IgA.
  • Hypogammaglobulinaemia was associated with more advanced disease, including organomegaly, anemia/thrombocytopenia, diffuse bone marrow infiltration, and higher lymphocytosis.
  • Patients with hypogammaglobulinaemia showed similar surface phenotypes to those with normal Ig levels.

Conclusions:

  • Hypogammaglobulinaemia in B-CLL is linked to a higher tumor burden rather than specific B-cell differentiation stages or phenotypes.
  • Serum Ig levels serve as a potential indicator of disease severity in B-CLL.
  • Further research into the mechanisms underlying hypogammaglobulinaemia in B-CLL is warranted.

More Related Videos

Lymphocyte Isolation from Human Skin for Phenotypic Analysis and Ex Vivo Cell Culture10:31

Lymphocyte Isolation from Human Skin for Phenotypic Analysis and Ex Vivo Cell Culture

Published on: April 8, 2016

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

Related Concept Videos

Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...